Robert Woods
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Derzeit hat R. Keith Woods die Position des Chief Operating Officer der argenx SE inne. In seiner früheren Laufbahn hatte er die Position des SVP-North American Operations bei Alexion Pharmaceuticals, Inc. und des Vice President & Managing Director bei Alexion Pharma UK Ltd. (eine Tochtergesellschaft von Alexion Pharmaceuticals, Inc.). Er erhielt einen Bachelor-Abschluss von der Florida State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.04.2026 | 48’034 ( 0.04% ) | 2 Mio $ | 31.05.2026 | |
| 09.06.2025 | 6’000 ( 0.01% ) | 25 860 $ | 31.05.2026 | |
-.--% | 07.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| 20.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 06.12.2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Geschäftsführer | 27.04.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.08.2025 |
| ROCKET PHARMACEUTICALS, INC. | Geschäftsführer | 18.06.2025 |
| ARGENX SE | Corporate Officer/Principal | 01.06.2023 |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen